Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daisuke Yoshinaga, M.D., Ph.D.

Concepts (64)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daisuke Yoshinaga's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daisuke Yoshinaga has written about over time.
Glucan 1,4-alpha-Glucosidase, 1 publications between 2018 and 2018, average publication date May 2018. Hypertension, Pulmonary, 1 publications between 2018 and 2018, average publication date September 2018. Lung Transplantation, 1 publications between 2018 and 2018, average publication date September 2018. Transposition of Great Vessels, 1 publications between 2018 and 2018, average publication date September 2018. Potassium Channel Blockers, 1 publications between 2019 and 2019, average publication date July 2019. Sodium Channel Blockers, 1 publications between 2019 and 2019, average publication date July 2019. Patch-Clamp Techniques, 3 publications between 2019 and 2021, average publication date July 2020. Biological Assay, 1 publications between 2021 and 2021, average publication date January 2021. Electrophysiological Phenomena, 2 publications between 2021 and 2021, average publication date January 2021. Tissue Array Analysis, 2 publications between 2021 and 2021, average publication date January 2021. Electrocoagulation, 1 publications between 2021 and 2021, average publication date July 2021. Hemostasis, Surgical, 1 publications between 2021 and 2021, average publication date July 2021. Neurofibroma, Plexiform, 1 publications between 2021 and 2021, average publication date July 2021. Induced Pluripotent Stem Cells, 7 publications between 2019 and 2024, average publication date October 2021. Myocytes, Cardiac, 7 publications between 2019 and 2024, average publication date October 2021. Action Potentials, 4 publications between 2019 and 2024, average publication date January 2022. Long QT Syndrome, 2 publications between 2019 and 2024, average publication date February 2022. Muscular Diseases, 1 publications between 2024 and 2024, average publication date April 2024. Calmodulin, 1 publications between 2024 and 2024, average publication date August 2024. Oligonucleotides, Antisense, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Yoshinaga's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.